Surgical biopsy is the gold standard for diagnosing central nervous system (CNS) lymphomas. However, reliable liquid biopsy methods for diagnosing CNS lymphomas have quickly developed and have been implicated in clinical decision-making. In the current report, we introduce two patients for whom liquid biopsy was essential for diagnosing CNS lymphomas and discuss the rapidly growing applications of this technology.
Keywords: Central nervous system lymphomas; Droplet digital PCR; Liquid biopsy.
© 2024. The Author(s), under exclusive licence to The Japan Society of Brain Tumor Pathology.